Skip to main content

Coronavirus: Disease Control

Question for Department of Health and Social Care

UIN 84280, tabled on 2 September 2020

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support longitudinal studies to track (a) the durability of the covid-19 immune response and (b) the long term disease consequences in covid-19 patients.

Answered on

15 September 2020

A number of different studies are considering the durability of the COVID-19 immune response, by assessing antibody waning over time and whether previous infection protects against future infection. This includes UK Biobank, REACT-2 and the Public Health England SIREN study.

The National Health Service and the wider scientific community are currently working to better understand the disease course of COVID-19 infection, including the prevalence, severity and duration of symptoms, and how best to support recovery. The National Institute for Health Research and UK Research and Innovation have invested £8.4 million in the Post-HOSPitalisation COVID-19 study (PHOSP-COVID), led by Christopher Brightling at the University of Leicester. This study is one of the world’s largest comprehensive research studies into the long-term health impacts of COVID-19 on hospitalised patients.